rsid,gene,trait,impact
rs6265,BDNF,Neuroplasticity,Reduced synaptic plasticity
rs4680,COMT,Cognitive control,Altered dopamine metabolism
rs7412,APOE,Alzheimer’s Disease,E2 protective or E4 risk
rs429358,APOE,Alzheimer’s Disease,E4 high-risk variant
rs4570625,SLC6A4,Depression,Increased susceptibility
rs1344706,ZNF804A,Schizophrenia,Increased risk
rs1006737,CACNA1C,Bipolar disorder,Confirmed association
rs17693963,GRM3,Schizophrenia,Cognitive processing involvement
rs3732378,NRG1,Neurodevelopment,Reduced signaling
rs3910105,HTR2A,Serotonin signaling,Depression susceptibility
rs1800497,ANKK1,Dopamine signaling,Reward sensitivity
rs1800955,DRD4,ADHD risk,Reduced dopamine receptor binding
rs1076560,DRD2,Schizophrenia risk,D1/D2 receptor balance
rs9320913,KIBRA,Memory function,Long-term memory strength
rs17070145,KIBRA,Memory and cognition,Hippocampal function
rs429358,APOE,Cognitive decline,Neurodegeneration risk
rs3736228,LRP5,Neurodevelopment,Bone and brain growth factor
rs2832407,GABRA2,Alcohol dependence,GABA signaling alteration
rs1160041,HTR1A,Anxiety,Serotonin receptor sensitivity
rs16969968,CHRNA5,Nicotine addiction,Reward pathway modulation
rs1799971,OPRM1,Opiate response,Altered pain and reward response
rs806377,CNR1,Cannabinoid signaling,Reward and anxiety modulation
rs324420,FAAH,Cannabis response,Reduced breakdown of endocannabinoids
rs1800795,IL6,Neuroinflammation,Elevated proinflammatory cytokine
rs1049353,CNR1,THC sensitivity,Increased psychoactive response
rs13212041,HTR1B,Impulse control,Serotonin modulation
rs6585018,OXTR,Social behavior,Oxytocin receptor expression
rs53576,OXTR,Empathy and stress,Reduced receptor function
rs11575542,MAOA,Violence/aggression risk,Monoamine metabolism
rs6323,MAOA,Depression and stress,Impaired serotonin turnover
rs6609257,SHANK3,Autism spectrum,Disrupted synaptic scaffolding
rs7794745,NRXN1,ASD susceptibility,Neurexin family dysfunction
rs7794745,NRXN1,Autism risk,Cell adhesion signaling
rs2710102,CNTNAP2,Language delay,Neural connectivity issues
rs4307059,MACROD2,Autism susceptibility,Neural development role
rs9873259,MEF2C,Intellectual disability,Transcription factor impact
rs17039988,GRIN2B,Learning disability,Glutamate receptor
rs3219151,HTR1A,Anxiety/depression,Mental health susceptibility
rs6295,HTR1A,Serotonin receptor,Mood and antidepressant sensitivity
rs160459,KANSL1,Dementia risk,Chromatin regulation
rs644148,GSK3B,Bipolar disorder,Lithium target pathway
rs11607159,NRXN3,Obesity and addiction,Neural reward link
rs17070145,KIBRA,Memory function,Long-term memory efficiency
rs1018381,DISC1,Schizophrenia,Neuronal migration defect
rs6675281,DISC1,Working memory,Cognitive load processing
rs10455872,LPA,Vascular dementia risk,Cholesterol & stroke
rs2075650,TOMM40,Alzheimer's Disease,Mitochondrial aging
rs11218343,SORL1,Alzheimer’s risk,Impaired amyloid clearance
rs4934,CLU,Neuroprotection,Chaperone activity decline
rs11136000,CLU,Alzheimer’s Disease,Cognitive resilience
rs610932,MS4A6A,Neurodegeneration,Risk locus
rs3865444,CD33,Microglial activation,Alzheimer’s inflammation
rs75932628,TREM2,Alzheimer’s Disease,Impaired immune response
rs1990622,TMEM106B,Frontotemporal dementia,Risk allele
rs157580,LPL,Dementia metabolism,Neuronal lipid metabolism
rs1800796,IL6,Neuroimmune aging,Cytokine activity
rs2736990,SNCA,Parkinson’s Disease,α-synuclein risk variant
rs356219,SNCA,Neurodegeneration,Increased α-synuclein expression
rs12185268,MAPT,Frontotemporal dementia,Tau protein regulation
rs1052553,MAPT,Parkinson’s risk,Microtubule stability
rs17651549,GRIN1,Excitotoxicity,Glutamate receptor hyperfunction
rs2075652,GSK3B,Neurodevelopment,Lithium modulation
rs2237717,CACNA1C,Neurocognition,Bipolar and schizophrenia overlap
rs12720208,BCL11A,Brain size,White matter and cognition
rs3732379,NRG1,Neural development,Myelination regulation
rs362273,RELN,Neurodevelopment and schizophrenia,Migration signals
rs6277,DRD2,Antipsychotic response,Dopamine D2 availability
rs17110432,GRM7,Depression susceptibility,Glutamate signaling
rs56164415,CACNA1C,Anxiety and bipolar,Excitatory neuron activity
rs11720469,GRIK1,Alcohol response,Excitatory neurotransmitter balance
rs15524,SLC6A3,Dopamine reuptake,ADHD and stimulant response
rs4074995,HTR2C,Weight gain from antipsychotics,Serotonin role
rs2296972,DRD1,Working memory,D1 receptor impact
rs1869458,HTR3A,SSRI nausea response,Serotonin-gated channel
rs2267735,ADCYAP1R1,PTSD risk,Stress hormone response
rs7131056,CACNA2D1,Epilepsy risk,Calcium channel sensitivity
rs2769605,SLC6A2,Norepinephrine transporter,ADHD and anxiety
rs2023239,CNR1,THC tolerance,CB1 receptor binding
rs5751876,ADORA2A,Caffeine anxiety,Sleep disturbance from stimulants
rs6313,HTR2A,Hallucinogen response,Serotonin binding
rs1835740,MOSPD3,Migraine risk,Glutamate pathway regulation
rs2070762,GLRB,Glycine receptor,Neurodevelopmental role
rs2234693,ESR1,Estrogen and cognition,Neuroprotective hormone pathway
rs17651549,GRIN1,Neuroexcitability,NMDA receptor regulation
rs2290588,CACNA1C,Epilepsy susceptibility,Excitability regulation
rs1800872,IL10,Neuroinflammation,Anti-inflammatory cytokine
rs2314339,BDNF,Memory performance,Exercise-induced growth
rs1344706,ZNF804A,Schizophrenia,Working memory alteration
rs11191580,NT5C2,Schizophrenia,Cognitive dysfunction link
rs2619538,GRM8,Anxiety disorder,Metabotropic glutamate signaling
rs6584400,NTRK2,Depression treatment response,BDNF signaling pathway
rs951266,GABRG2,Seizure threshold,Inhibitory control
rs15524,DRD2,Antipsychotic response,Dopaminergic effect
rs11191280,GRIN2B,Learning capacity,Glutamatergic signaling
rs1858830,SLITRK1,Tourette syndrome,Axon guidance genes
rs1360780,FKBP5,Stress reactivity,Glucocorticoid regulation
rs356168,SNCA,Parkinson’s Disease,Alpha-synuclein regulation
rs2030324,GRIK2,Cognition,Glutamate ionotropic receptor
rs13212041,HTR1B,Impulsivity,Dopamine-serotonin modulation
rs12913832,OCA2,Eye-brain development,Cognitive-visual link
rs521674,HTR2A,SSRI side effects,Pharmacogenetic sensitivity
rs2228570,VDR,Cognition & aging,Vitamin D receptor and neurofunction
rs2236225,MTHFD1,Neurodevelopment,One-carbon metabolism
rs1801394,MTRR,Brain methylation,Neurodevelopmental function
rs1255998,OPRM1,Addiction vulnerability,Mu-opioid receptor
rs6269,COMT,Prefrontal dopamine,Working memory efficiency
rs2070762,GABRA4,Autism and anxiety,Inhibitory neurotransmitter
rs6311,HTR2A,Depression and SSRI response,5-HT2A receptor sensitivity
rs2439272,CACNB2,Bipolar and cardiac overlap,Calcium channel function
rs7982,SNAP25,Schizophrenia,Ca2+-dependent neurotransmitter release
rs7597593,GRIN3B,Cognition,Memory and executive function
rs1142523,GAD1,GABA synthesis,Neural inhibition efficiency
rs1129649,GABRA6,Anxiety and stress,Receptor subtype modulation
rs7048425,NPY,Appetite and anxiety,Stress response peptide
rs6313,HTR2A,Serotonergic cognition,Cognitive emotional regulation
rs6296,HTR1B,Aggression and risk,Serotonin regulation in PFC
rs2296972,DRD1,Cognitive effort,Attention modulation
rs10770141,TYR,Neurodevelopment,Melanin/dopamine pathway
rs1076560,DRD2,Cognitive flexibility,Reward prediction error
rs10994336,ANK3,Bipolar disorder,Node of Ranvier and excitability
rs3792452,NOS1,Neurotransmitter synthesis,Brain nitric oxide signaling
rs1360780,FKBP5,Stress regulation,Early trauma sensitivity
rs1378810,PLCB1,Neurodevelopment,Signal transduction in brain
rs2710102,CNTNAP2,Language acquisition,Neuronal connectivity
rs7859271,PTPRG,Autism and ADHD,Cell adhesion and synapse function
rs10897284,SRR,Glutamate conversion,Schizophrenia risk
rs1018381,DISC1,Neurodevelopment,Dysregulation in schizophrenia
rs7766029,CHRNA4,Nicotine and memory,Receptor binding affinity
rs2234693,ESR1,Hormonal neuroprotection,Cognitive resilience
rs17782313,MC4R,Obesity-linked cognition,Energy balance and memory
rs11603044,DLG4,Synaptic scaffolding,Plasticity and behavior
rs1869458,HTR3A,SSRI side effects,Nausea modulation
rs3778150,CNTNAP2,Neural circuitry,Autism and epilepsy
rs1076560,DRD2,D2 receptor isoform,Cognitive task modulation
rs1799913,MAOB,Dopaminergic control,Neurotransmitter clearance
rs1042778,OXTR,Social anxiety,Oxytocin receptor density
rs1447295,AR,Neuroendocrine interaction,Sex differences in risk
rs4916723,CHRNA3,Nicotine dependence,Cognitive disinhibition
rs3813714,SNAP25,Memory encoding,Neurotransmitter release speed
rs26907,NR4A2,Dopaminergic neuron fate,Parkinson’s risk
rs3782219,RELN,Autism and cognition,Reelin signal modulation
rs2814707,SLC6A4,Depression,Serotonin transporter polymorphism
rs4657412,NRXN1,Neuronal connectivity,Language and memory
rs4880,SOD2,Neuroprotection,Oxidative stress resistance
rs6265,BDNF,Neural growth,Response to exercise and cognition
---